Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?

Antiviral therapy - 1 Jan 2007

Uy Jonathan, Brooks John T, Baker Rose, Hoffman Mark, Moorman Anne, Novak Richard

Abstract excerpt

BACKGROUND: Clinical utilization of genotype resistance testing is evolving. We examined the extent to which HIV care providers requesting genotype resistance tests used the information appropriately and the impact of inappropriate utilization. METHODS: Data from a prospective cohort of HIV-infected patients (the HIV Outpatient Study) were used in the analysis. We analysed the frequency with which patients were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to HIV Reverse Transcriptase

Share to Nelfinavir

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 17926650

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?PMID 17926650Read ↗

Impact of genotypic resistance testing on physician selection of antiretroviral therapy.Semantic proximity Read ↗

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.Semantic proximity Read ↗

[Clinical use of HIV-1 resistance genotyping. Predictive factors of poor virological evolution in salvage treatments].Semantic proximity Read ↗

Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads.Semantic proximity Read ↗

Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006.Semantic proximity Read ↗

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.Semantic proximity Read ↗

Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis.Semantic proximity Read ↗

Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care.Semantic proximity Read ↗

Factors associated with the successful modification of antiretroviral therapy. HIV Outpatient Study Investigators.Semantic proximity Read ↗

GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.Semantic proximity Read ↗

Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.Semantic proximity Read ↗

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.